Correlation Between Karyopharm Therapeutics and Valneva SE
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Valneva SE ADR, you can compare the effects of market volatilities on Karyopharm Therapeutics and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Valneva SE.
Diversification Opportunities for Karyopharm Therapeutics and Valneva SE
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Karyopharm and Valneva is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Valneva SE go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Valneva SE
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Valneva SE. But the stock apears to be less risky and, when comparing its historical volatility, Karyopharm Therapeutics is 2.24 times less risky than Valneva SE. The stock trades about -0.65 of its potential returns per unit of risk. The Valneva SE ADR is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 430.00 in Valneva SE ADR on September 25, 2024 and sell it today you would lose (11.00) from holding Valneva SE ADR or give up 2.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Karyopharm Therapeutics vs. Valneva SE ADR
Performance |
| Timeline |
| Karyopharm Therapeutics |
| Valneva SE ADR |
Karyopharm Therapeutics and Valneva SE Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karyopharm Therapeutics and Valneva SE
The main advantage of trading using opposite Karyopharm Therapeutics and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
| Valneva SE vs. Fate Therapeutics | Valneva SE vs. Caribou Biosciences | Valneva SE vs. Karyopharm Therapeutics | Valneva SE vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |